Effects of the glucose-lowering rate on cTnI and hs-CRP serum levels in type 2 diabetics

Human Immunology

Volumn 74, Issue 3, 2013, Pages 379-382

  Wu, Weihua ^a   Li, Qian ^a   Xia, Jing ^a   Wang, Mingli ^b   Sun, Zhenjie ^c   Miao, Jiajing ^d   Zheng, Zhaohui ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c TANGSHAN GONGREN HOSPITAL   (China)

^d Affiliated Hospital of Jilin Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN; METFORMIN; TROPONIN I;

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN PUMP; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I;

EID: 84873710754     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.11.017     Document Type: Article

References (10)

1. The Action to Control Cardiovascular Risk in Diabetes StudyGroup Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2009, 358:2545-2559.
2. The ADVANCE collaborative group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2009, 358:2560-2572.
3. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 2009(360):129-139.
4. Ess S.M., Szucs T.D. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. Ananalysis in Germany and Italy. Ital Heart J 2001, 2(3):181-188.
5. Libby Peter, Ridker Paul M., Göran K., Hansson Inflammation in Atherosclerosis: From Pathophysiology to Practice. J Am Coll Cardiol 2009, 54(23):2129-2138.
6. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without priormyocardial infarction. N Engl J Med 1998, 339(4):229-234.
7. Van de Casteele M., Kefas B.A., Cai Y., Heimberg H., Scott D.K., Henquin J.C., et al. Prolonged culture in low glucose induces apoptosis of rat pancreatic beta-cells through induction of c-myc. Biochem Biophys Res Commun 2003, 312(4):937-944.
8. Ghanim H., Aljada A., Hofmeyer D., Syed T., Mohanty P., Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004, 110(12):1564-1571.
9. Risso A., Mercuri F., Quagliaro L., Damante G., Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 2001, 281(5):E924-E930.
10. El-Osta A., Brasacchio D., Yao D., Pocai A., Jones P.L., Roeder R.G., et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008, 205(11):2683.